We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
-7.25%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$171M
AUM Growth
+$4.01M
Cap. Flow
+$16.8M
Cap. Flow %
9.85%
Top 10 Hldgs %
55.16%
Holding
228
New
107
Increased
39
Reduced
38
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 4.05%
2 Communication Services 3.01%
3 Financials 1.84%
4 Healthcare 1.26%
5 Consumer Staples 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUAD icon
151
Quad
QUAD
$536M
$69K 0.04%
+10,000
New +$52.4K
IDEV icon
152
iShares Core MSCI International Developed Markets ETF
IDEV
$31.7B
$62K 0.04%
+970
New +$62.4K
BGY icon
153
BlackRock Enhanced International Dividend Trust
BGY
$524M
$58K 0.03%
+10,000
New +$59.4K
IVLU icon
154
iShares MSCI Intl Value Factor ETF
IVLU
$4.42B
$58K 0.03%
+2,276
New +$58.9K
TRHC
155
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$58K 0.03%
+10,023
New +$90K
IMCG icon
156
iShares Morningstar Mid-Cap Growth ETF
IMCG
$3.92B
$57K 0.03%
886
+115
+15% +$7.41K
AMRN
157
Amarin Corp
AMRN
$299M
$53K 0.03%
+805
New +$53.1K
VTI icon
158
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
$51K 0.03%
226
-539
-70% -$121K
NCV
159
Virtus Convertible & Income Fund
NCV
$378M
$50K 0.03%
+2,500
New +$51.3K
GDX icon
160
VanEck Gold Miners ETF
GDX
$22.6B
$46K 0.03%
1,206
OLMA icon
161
Olema Pharmaceuticals
OLMA
$1B
$43K 0.03%
+10,000
New +$55.1K
LJPC
162
DELISTED
La Jolla Pharmaceutical Company
LJPC
$43K 0.03%
+10,000
New +$43.6K
AMRX icon
163
Amneal Pharmaceuticals
AMRX
$5.85B
$42K 0.02%
+10,000
New +$44.3K
GRTS
164
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$41K 0.02%
+10,000
New +$53K
JIG icon
165
JPMorgan International Growth ETF
JIG
$471M
$39K 0.02%
632
-300
-32% -$19.6K
EMGF icon
166
iShares Emerging Markets Equity Factor ETF
EMGF
$1.82B
$36K 0.02%
736
INO icon
167
Inovio Pharmaceuticals
INO
$55.7M
$36K 0.02%
+833
New +$37.5K
SCTL
168
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$36K 0.02%
+20,000
New +$34.6K
AAIC
169
DELISTED
Arlington Asset Investment Corp.
AAIC
$35K 0.02%
+10,000
New +$34.5K
VOE icon
170
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$33K 0.02%
219
+80
+58% +$11.8K
DHC
171
Diversified Healthcare Trust
DHC
$2.15B
$32K 0.02%
+10,000
New +$30.5K
PBYI icon
172
Puma Biotechnology
PBYI
$404M
$29K 0.02%
+10,000
New +$25.9K
IAGG icon
173
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
$28K 0.02%
+545
New +$29K
AQST icon
174
Aquestive Therapeutics
AQST
$464M
$26K 0.02%
+10,000
New +$29.2K
BWZ icon
175
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$269M
$26K 0.02%
903

Similar funds

Running Point Capital Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Running Point Capital Advisors held 228 positions worth $171M, up 2.4% from $167M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Running Point Capital Advisors deployed $16.8M of net new capital in Q1 2022, opening 107 new positions and adding to 39 existing holdings. Its largest new stake was JPMorgan International Bond Opportunities ETF: 11,412 shares worth $558K.

By sector, the portfolio is most concentrated in Technology at 4% of assets, down from 5.6% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $2.01M trimmed.

  • Running Point Capital Advisors's largest Q1 2022 buy was JPMorgan International Bond Opportunities ETF: 11,412 shares worth $558K.
  • Running Point Capital Advisors added most to iShares Core MSCI Emerging Markets ETF in Q1 2022, an estimated $3.44M increase.
  • Running Point Capital Advisors's biggest Q1 2022 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $2.01M.
  • Running Point Capital Advisors fully exited Starbucks in Q1 2022, selling an estimated $279K.
  • Running Point Capital Advisors's ten largest holdings make up 55% of its $171M portfolio in Q1 2022.
  • Running Point Capital Advisors opened 107 new positions and closed 10 in Q1 2022.
  • Running Point Capital Advisors's portfolio value rose 2.4% quarter-over-quarter to $171M.

Based on Running Point Capital Advisors's 13F filing for Q1 2022, filed 12 May 2022.